Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: Protocol for a modified e-Delphi study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 04 07 2022
accepted: 25 09 2022
entrez: 11 10 2022
pubmed: 12 10 2022
medline: 14 10 2022
Statut: epublish

Résumé

Individual participant data meta-analyses enable detailed checking of data quality and more complex analyses than standard study-level synthesis of summary data based on publications. However, there is limited existing guidance on the specific systematic checks that should be undertaken to confirm and enhance data quality for individual participant data meta-analyses and how to conduct these checks. We aim to address this gap by developing a checklist of items for data quality checking and cleaning to be applied to individual participant data meta-analyses of randomised trials. This study will comprise three phases: 1) a scoping review to identify potential checklist items; 2) two e-Delphi survey rounds among an invited panel of experts followed by a consensus meeting; and 3) pilot testing and refinement of the checklist, including development of an accompanying R-markdown program to facilitate its uptake.

Identifiants

pubmed: 36219622
doi: 10.1371/journal.pone.0275893
pii: PONE-D-22-18844
pmc: PMC9553056
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0275893

Subventions

Organisme : Medical Research Council
ID : MC_UU_00004/06
Pays : United Kingdom

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: KEH receives research funding support via two scholarships administered by the University of Sydney (Postgraduate Research Supplementary Scholarship in Methods Development (SC3504), and Research Training Program Stipend (SC3227)). ALS is co-convenor and KEH & ACW are associate convenors of the Cochrane Prospective Meta-analysis Methods Group. MJP is recipient of the Australian Research Council Discovery Early Career Researcher Award (DE200101618), co-convenor of the Cochrane Bias Methods Group, and President of the Association for Interdisciplinary Meta-research and Open Science. RW is recipient of a National Health and Medical Research Council Investigator Grant. VB is supported by an Alfred Deakin Postdoctoral Research Fellowship. MC is co-convenor (unpaid) of the Cochrane Individual Participant Data Meta-analysis Methods Group; LHMR is coordinator of this group; KEH, PJG, BWM, MC and ALS are members. LHMR is supported by the UK Medical Research Council (https://protect-au.mimecast.com/s/iksjCK1DvKTqkx5mBI3AxP2?domain=mrc.ukri.org) Grant number: MC_UU_00004/06. ALS is recipient of a National Health and Medical Research Council Investigator Grant. BWM is recipient of a National Health and Medical Research Council Investigator grant (GNT1176437), reports consultancy for ObsEva at an hourly rate, reports consultancy for Merck Merck KGaA at an hourly rate and received travel support from Merck Merck KGaA. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

J Clin Epidemiol. 2021 Aug;136:227-234
pubmed: 34044099
J Clin Epidemiol. 2021 Aug;136:224-226
pubmed: 34004337
BMJ. 2015 Mar 06;350:h1088
pubmed: 25747860
J Clin Epidemiol. 2021 Aug;136:189-202
pubmed: 34033915
J Clin Epidemiol. 2021 Aug;136:221-223
pubmed: 34010711
J Clin Epidemiol. 2021 Jan;129:31-39
pubmed: 32991995
Arch Dis Child. 2005 Aug;90(8):845-8
pubmed: 16040886
J Adv Nurs. 1994 Jun;19(6):1221-5
pubmed: 7930104
PLoS One. 2018 Jul 30;13(7):e0201378
pubmed: 30059560
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Adv Nurs. 2006 Jan;53(2):205-12
pubmed: 16422719
Health Technol Assess. 2015 Aug;19(68):1-374
pubmed: 26321161
JMIR Res Protoc. 2020 Jan 8;9(1):e15910
pubmed: 31913133
BMJ. 2021 Apr 19;373:n736
pubmed: 33875446
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294

Auteurs

Kylie E Hunter (KE)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Angela C Webster (AC)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Mike Clarke (M)

School of Medicine, Dentistry and Biomedical Sciences, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.

Matthew J Page (MJ)

Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Sol Libesman (S)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Peter J Godolphin (PJ)

MRC Clinical Trials Unit at University College London, London, United Kingdom.

Mason Aberoumand (M)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Larysa H M Rydzewska (LHM)

MRC Clinical Trials Unit at University College London, London, United Kingdom.

Rui Wang (R)

Department of Obstetrics and Gynaecology, Monash Health, Monash University, Melbourne, Victoria, Australia.

Aidan C Tan (AC)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Wentao Li (W)

Department of Obstetrics and Gynaecology, Monash Health, Monash University, Melbourne, Victoria, Australia.

Ben W Mol (BW)

Department of Obstetrics and Gynaecology, Monash Health, Monash University, Melbourne, Victoria, Australia.

Melina Willson (M)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Vicki Brown (V)

Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Faculty of Health, Deakin University, Burwood, Victoria, Australia.

Talia Palacios (T)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Anna Lene Seidler (AL)

NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH